Locally manufactured biologics include insulin, epoetin, filgrastim, streptokinase, and rituximab. Over 40 biologics are marketed in India, of which around 25 are biosimilars that are manufactured ...

The patent for Humira, the world’s bestselling drug, expires in Europe today – opening the door for a host of cheaper biosimilars to hit the market. Sales of AbbVie’s Humira (adalimumab ...